NCM Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$822K Sell
2,335
-14
-0.6% -$4.99K 0.29% 83
2025
Q4
$769K Buy
2,349
+1
+0% +$317 0.29% 88
2025
Q3
$663K Sell
2,348
-10
-0.4% -$2.9K 0.26% 92
2025
Q2
$658K Buy
2,358
+11
+0.5% +$3.12K 0.27% 86
2025
Q1
$731K Sell
2,347
-90
-4% -$26.6K 0.33% 78
2024
Q4
$635K Buy
2,437
+8
+0.3% +$2.37K 0.29% 85
2024
Q3
$783K Hold
2,429
0.38% 70
2024
Q2
$759K Hold
2,429
0.4% 62
2024
Q1
$691K Sell
2,429
-10
-0.4% -$2.93K 0.39% 70
2023
Q4
$702K Sell
2,439
-10
-0.4% -$2.73K 0.43% 64
2023
Q3
$658K Sell
2,449
-10
-0.4% -$2.5K 0.47% 61
2023
Q2
$546K Buy
2,459
+10
+0.4% +$2.32K 0.38% 73
2023
Q1
$592K Sell
2,449
-10
-0.4% -$2.46K 0.44% 65
2022
Q4
$646K Sell
2,459
-10
-0.4% -$2.68K 0.43% 70
2022
Q3
$557K Buy
2,469
+20
+0.8% +$4.85K 0.42% 74
2022
Q2
$596K Hold
2,449
0.42% 78
2022
Q1
$592K Buy
2,449
+17
+0.7% +$3.91K 0.37% 89
2021
Q4
$547K Buy
+2,432
New +$513K 0.49% 64

Other funds holding AMGN

NCM Capital Management's AMGN Position: Q1 2026 in Review

NCM Capital Management reduced its Amgen (AMGN) stake by 0.6% in Q1 2026, selling an estimated $4.99K and leaving 2,335 shares worth $822K. The position accounts for 0.29% of the portfolio, ranked #83.

NCM Capital Management first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • NCM Capital Management held 2,335 shares of Amgen worth $822K as of Q1 2026.
  • NCM Capital Management sold 14 Amgen shares in Q1 2026, an estimated $4.99K.
  • Amgen made up 0.29% of NCM Capital Management's portfolio in Q1 2026, its #83 holding.
  • NCM Capital Management first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on NCM Capital Management's 13F filing for Q1 2026, filed 15 May 2026.